Literature DB >> 30927065

Epidural analgesia vs systemic opioids in patients undergoing laparoscopic colorectal surgery.

Stefano Turi1, Marco Gemma2, Marco Braga3, Roberta Monzani4, Danilo Radrizzani5, Luigi Beretta6.   

Abstract

PURPOSE: A well-controlled pain is one of the most important targets of enhanced recovery after surgery (ERAS) protocols. Recent studies questioned the role of TEA (thoracic epidural analgesia) in support of less invasive techniques, in particular in laparoscopic mini-invasive surgery. The aim of this study is to compare patients undergoing laparoscopic mini-invasive colorectal surgery and receiving different analgesic techniques.
METHODS: Prospectively collected data entered in the electronic registry of POIS (Perioperative Italian Society) specifically designed for ERAS were reviewed. Patients undergoing colorectal laparoscopic surgery were divided in two groups according to TEA or parenteral opioid administration. In comparing TEA and opioid groups, propensity score weights were obtained. Postoperative pain control and time to readiness for discharge (TRD) were considered as primary endpoints of the study. Secondary endpoints were postoperative morbidity, PONV (postoperative nausea and vomiting), hours of mobilization, length of hospital stay (LOS), timing of fluid and solid re-assumption, and recovery of bowel function.
RESULTS: Fourteen Italian hospitals reported data on 560 patients (283 TEA, 277 opioid group). Patients of the opioid group were able to mobilize for a longer period than TEA group patients but presented a higher incidence of PONV. Pain intensity and TRD were similar in both groups. LOS was significantly reduced in TEA patients; also, this result was clinically irrelevant (5.7 ± 3.21 days TEA group vs 5.8 ± 2.92 opioid group).
CONCLUSION: In patients undergoing laparoscopic colorectal surgery, TEA was not associated to a better pain control or to an improvement in postoperative outcome compared with opioid administration.

Entities:  

Keywords:  Epidural analgesia; Laparoscopic colorectal surgery; Systemic opioids

Mesh:

Substances:

Year:  2019        PMID: 30927065     DOI: 10.1007/s00384-019-03284-4

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  4 in total

1.  [Epidural block associated with improved long-term survival after surgery for colorectal cancer: A retrospective cohort study with propensity score matching].

Authors:  D L Mu; C Xue; B An; D X Wang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

2.  Sufentanil Sublingual Tablet System (SSTS) for the management of postoperative pain after major abdominal and gynecological surgery within an ERAS protocol: an observational study.

Authors:  Stefano Turi; Francesco Deni; Gaetano Lombardi; Marilena Marmiere; Francesco Giuseppe Nisi; Luigi Beretta
Journal:  J Pain Res       Date:  2019-07-26       Impact factor: 3.133

3.  Studying Enhanced Recovery After Surgery (ERAS®) Core Items in Colorectal Surgery: A Causal Model with Latent Variables.

Authors:  Marco Gemma; Fulvia Pennoni; Marco Braga
Journal:  World J Surg       Date:  2021-02-11       Impact factor: 3.352

4.  Evaluation of analgesic effects and hemodynamic responses of epidural ropivacaine in laparoscopic abdominal surgeries: Randomised controlled trial.

Authors:  Dipti Jayadevan; Lakshmi Kumar; Rekha Varghese; Sindhu Balakrishnan; P Shyamsundar; Rajesh Kesavan
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2022-02-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.